genedrive plc (AIM:GDR)
London
· Delayed Price · Currency is GBP · Price in GBX | Market Cap | 14.69M |
| Revenue (ttm) | 1.17M |
| Net Income (ttm) | -5.34M |
| Shares Out | 1.61B |
| EPS (ttm) | -0.01 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 2,221,289 |
| Average Volume | 4,685,953 |
| Open | 0.950 |
| Previous Close | 0.975 |
| Day's Range | 0.900 - 1.000 |
| 52-Week Range | 0.190 - 1.875 |
| Beta | 1.00 |
| RSI | 41.33 |
| Earnings Date | Apr 2, 2026 |
About genedrive
genedrive plc engages in the design, development, and manufacture of molecular diagnostics testing equipment for use in genotyping, pathogen detection, infectious disease detection, and other clinical indications. The company provides Genedrive system, rapid nucleic acid thermocycler and fluorescence signal detection system for target discrimination used for qualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a certified test for identification of individuals unlikely to respond to the commonly prescribed antiplatelet... [Read more]
Financial Performance
In fiscal year 2025, genedrive's revenue was 954,000, an increase of 90.42% compared to the previous year's 501,000. Losses were -5.23 million, -26.06% less than in 2024.
Financial StatementsNews
AIM Market Roundup: Trellus Health, Genedrive, Mycelx
Trellus Health, Genedrive, Mycelx are today's top risers, while CPP, PetroTal take the biggest fall on London's AIM market
genedrive Earnings Call Transcript: H2 2025
Rapid pharmacogenetic tests for emergency care are gaining traction, with FY25 revenue reaching GBP 1 million and strong clinical adoption in the U.K. and abroad. Regulatory progress, pilot programs, and new funding position the company for further growth, though additional capital is needed.
AIM Market Roundup: Genedrive, Idox, Diales
Genedrive, Idox, Diales are today's top risers, while Future Metals, Team take the biggest fall on London's AIM market
AIM Market Roundup: Proteome Sciences, TAP Global, Various Eateries
Proteome Sciences, TAP Global, Various Eateries are today's top risers, while Arc Minerals, Genedrive take the biggest fall on London's AIM
AIM Market Roundup: Genedrive, Petro Matad, Alien Metals
ABC are today's biggest risers and fallers on London's AIM market
AIM Market Roundup: Future Metals, Renalytix, Nativo Resources
Future Metals, Renalytix, Nativo Resources are today's top risers, while genedrive, Rentguarantor take the biggest fall on London's AIM
AIM Market Roundup: 80 Mile, TAP Global, Genedrive
80 Mile, TAP Global, Genedrive are today's top risers, while Active Energy, Finseta take the biggest fall on London's AIM market
AIM Market Roundup: Ethernity, Touchstone, Caledonian Holdings
Ethernity, Touchstone, Caledonian Holdings are today's top risers, while Metals One, Genedrive take the biggest fall on London's AIM market
genedrive Earnings Call Transcript: H2 2024
Revenue grew to GBP 500,000 as adoption of two innovative pharmacogenetic tests increased, though losses widened due to R&D and scaling costs. Regulatory progress, strong clinical endorsements, and expanding international traction position the company for future growth.
Small Cap Stocks: Genedrive, Tern, Conroy Gold
Genedrive, Tern, Mobile Tornado, Conroy Gold, Nativo Resources are today's biggest Small Cap stock movers